Join
Live feed
·
INSIDERFilingvia Quantisnow
Design Therapeutics Inc. logo

SEC Form 4: William Arsani bought $474,680 worth of shares (25,000 units at $18.99)

ByQuantisnow·Wall Street's wire, on your screen.
DSGN· Design Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DSGN (Design Therapeutics Inc.) and more on Quantisnow.